Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and tolerance of LBC 45 in seborrheic dermatitis of the scalp
2009-013120-23Phase 2Active
- Sponsor
- Labcatal
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in seborrheic dermatitis (SD) comparing LBC 45 with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint at Week 8. Started Aug 2009; status: active.
02
Drugs
lithium gluconate
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on 2009-013120-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013120-23.